Early Use of Sotrovimab in Children: A Case Report of an 11-Year-Old Kidney Transplant Recipient Infected with SARS-CoV-2

Background: The use of virus-neutralizing monoclonal antibodies has been approved in fragile populations, including kidney transplant recipients, who are at risk of developing severe COVID-19. Sotrovimab is the only currently available anti-SARS-CoV-2 neutralizing monoclonal antibody with activity a...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Chiara, Costanza, Mengato, Daniele, De Pieri, Marica, Longo, Germana, Benetti, Elisa, Venturini, Francesca, Giaquinto, Carlo, Donà, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028505/
https://www.ncbi.nlm.nih.gov/pubmed/35455495
http://dx.doi.org/10.3390/children9040451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028505/
https://www.ncbi.nlm.nih.gov/pubmed/35455495
http://dx.doi.org/10.3390/children9040451

Ejemplares similares